Medigene AG: Medigene’s Academic Partners Provide Update on Planned MAGE-A1-specific TCR Clinical IIT during CIMT
Planegg (pta/08.05.2018/07:30) Medigene AG (MDG1, Frankfurt, Prime Standard), announced that researchers from Max-Delbrück-Center for Molecular Medicine (MDC) and Charité, both in Berlin